Curevac Nv
- All
- News
'Curevac Nv' - 1 News Result(s)
-
CureVac Fails In Pivotal COVID-19 Vaccine Trial With 47% Efficacy
German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union.
'Curevac Nv' - 1 News Result(s)
-
CureVac Fails In Pivotal COVID-19 Vaccine Trial With 47% Efficacy
German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union.
